Navigation Links
The new born nightmare

Newborns are more likelier to develop a serious intestinal disorder if they are given the commonly prescribed antibiotic erythromycin, say US scientists. A research team from Lousiana University has linked use of this drug to pyloric stenosis, a condition that affects about 1 in 400 newborns and it is the most common cause of abdominal surgery in infants.

Using the Regenstrief Medical Record System – a comprehensive database that stores information on diagnoses, operative reports, pharmacy records and physician observations –the investigators studied 13,576 babies born between January 1995 and December 2000.//

They found that those babies given oral erythromycin during the first two weeks of life were 12 times more likely to develop pyloric stenosis than those who were not, although babies treated with erythromycin eye ointment, which is regularly used to combat conjunctivitis, did not have much risk.

“The link between erythromycin and pyloric stenosis is an important finding which will make a difference to the health of babies,” said Dr Lida Carlman, the lead researcher, adding that the study was only made possible by the vast amount of data stored in the Regenstrief system.

The researchers conclude that erythromycin should be used with great precaution in a baby’s first four weeks of life.
br>
'"/>




Page: 1

Related medicine news :

1. Wake-up Call: Two-thirds of Briton Spend Many Sleeping Moments Awake!
2. A Wake-up Call by MPs to Ensure Timely Care to Stroke Victims
3. Stem cell cure for peripheral vascular disease: New hope on the horizon
4. New device for detecting artery blockages
5. Vitamins suppress artery injury after transplant
6. Cocaine may cause aneurysms for the coronart artery
7. Soy, Omega 3s convalesce artery health
8. Erectile dysfunction: an early warning sign of clinically silent coronary artery disease?
9. Experts urging artery screening in the UK
10. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
11. Fight Heart disease and Pain with Meditation
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased to announce the ... July 17, 2017, Ms. Vu will join West Dermatology’s large network of medical and ... skin cancer , and more. She graduated from the University of Florida College ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... concussion rates are on the rise, say researchers presenting their work at the ... Ontario, Canada. , “The combination of evaluating the patterns of change in concussion ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia ... that progresses rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and ... and relapse. With such a challenging diagnosis that requires immediate action, patients ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing homes, ... designed to accommodate patients with a wide range of ailments or special needs, but ... invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many uses, ...
(Date:7/20/2017)... , ... July 20, 2017 , ... Doctors on Liens, ... addition of Horine Chiropractic , directed by Dr. Russell Horine, DC to their ... completely family run with Dr. Russell Horine serving as the clinic director and his ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... July 11, 2017  Sysmex America, Inc., a ... testing equipment as well as middleware information systems ... to make quality assurance easier and more risk ... well known for the innovation that it delivers ... elevates quality assurance processes to a new level ...
(Date:7/11/2017)... JERUSALEM , July 11, 2017 Oramed ... ), a clinical-stage pharmaceutical company focused on the development ... U.S. Food and Drug Administration (FDA) has agreed to ... successfully completed Phase IIb trial of its oral insulin ... The Phase IIb trial met primary and secondary endpoints ...
(Date:7/10/2017)... , July 10, 2017 The Institute for ... methods, is the recipient of a VITROCELL® inhalation exposure ... International Science Consortium. The device, which is designed to ... expose human lung cells to airborne test materials in ... use the VITROCELL® system for testing combustible tobacco products, ...
Breaking Medicine Technology: